Laboratory Testing for a Healthy 25-Year-Old at First Primary Care Visit
For a healthy, slightly overweight 25-year-old with no complaints at their first primary care visit, order a fasting lipid panel and fasting glucose (or hemoglobin A1c). Additional testing should be limited and based only on specific risk factors identified during history and physical examination.
Core Recommended Testing
Metabolic Screening (Age and Weight-Based)
- Fasting lipid profile (total cholesterol, LDL-C, HDL-C, triglycerides) 1, 2
- Fasting glucose or hemoglobin A1c 1, 3
The 2024 ADA guidelines recommend screening for diabetes starting at age 35, but earlier screening is appropriate for overweight individuals (BMI ≥25) 3. Given this patient is "slightly overweight," metabolic screening is justified even at age 25 2.
Why This Limited Approach?
The evidence strongly supports selective rather than comprehensive laboratory testing in asymptomatic young adults. Research demonstrates that 58-92% of physicians order inappropriate screening tests for healthy patients, with an average of 3.3-5.7 unnecessary tests per encounter 4. The most common cause of abnormal results in screening healthy patients is physiologic or laboratory variation, not disease 5, 6.
What NOT to Order Routinely
Avoid ordering these tests without specific clinical indications:
- Complete blood count
- Comprehensive metabolic panel
- Liver function tests
- Thyroid function tests
- Urinalysis
- Renal function tests
These tests are only indicated if specific symptoms, risk factors, or clinical findings suggest underlying disease 7, 4. Guidelines for heart failure, HIV, and other specific conditions recommend comprehensive laboratory panels, but these apply to symptomatic patients or those with established disease—not healthy young adults 8.
Risk-Stratified Additional Testing
Consider Adding If Specific Risk Factors Present:
For metabolic syndrome screening (if BMI ≥25 plus additional risk factors):
- Liver function tests to screen for NAFLD 9, 2
- Calculate Fibrosis-4 (FIB-4) score if NAFLD suspected 9
For sexually active patients or those with exposure risks:
- STI screening (gonorrhea, chlamydia via NAAT; syphilis serology) 10
- HIV screening (if not previously tested)
- Hepatitis B and C screening (based on risk factors) 10
For specific ethnic/racial backgrounds:
- Hemoglobin A1c may be particularly useful in Asian and Hispanic populations (higher rates of undiagnosed diabetes) 3
Clinical Pitfalls to Avoid
Overtesting drives unnecessary follow-up: Each "abnormal" result outside the reference range (which occurs in 5% of healthy individuals by definition) triggers additional testing, patient anxiety, and healthcare costs 6
Physician factors drive overtesting more than patient factors: Practice patterns, specialty training, and previous testing habits influence ordering more than actual patient need 7
"Routine panels" are not evidence-based: The practice of ordering comprehensive metabolic panels, CBCs, and other broad testing for healthy young adults lacks guideline support and generates more harm than benefit through false positives 4, 5
The Evidence Hierarchy
The 2024 Diabetes Care guidelines 1 and 2023 obesity management guidelines 2 provide the most recent, high-quality evidence for metabolic screening in this age group. These supersede older general screening recommendations and specifically address the overweight/obesity context. The ADA recommends screening starting at age 35 for average-risk individuals, but explicitly states earlier screening for those who are overweight with additional risk factors 3.
The key principle: Order tests to confirm clinical suspicions from history and physical examination, not as broad screening in asymptomatic patients 5. The most meaningful laboratory data comes from targeted testing based on specific clinical questions, not reflexive ordering of comprehensive panels.